medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2018, Number 3

<< Back Next >>

Rev Mex Urol 2018; 78 (3)

Prevalence of overactive bladder in Mexico City. Results of a preliminary analysis

Cruz-Ruíz J, Farrera-González V, Ransom-Rodríguez A, Avalos-Jiménez JC, Landa-Soler M, González-Serrano A, Cortez-Betancourt R, Marín-Acosta DJ, Torres-Aguilar J, Herrera-Muñoz JA, Cantellano-Orozco M, Castro-Marín M, Sosa-Anau N, García-Mora A, Rodríguez-Covarrubias F

Language: Spanish
References: 21
Page: 189-196
PDF size: 296.54 Kb.


ABSTRACT

Objective: To determine the prevalence of overactive bladder and the degree of impact it has on the quality of life of patients recruited from five hospital centers in Mexico City.
Materials and Methods: A descriptive, observational, cross-sectional study was conducted through the prospective collection of patient data from the General Medicine, Family Medicine, or Internal Medicine outpatient consultation at five hospital centers in Mexico City, within the time frame of January and December 2017. Participants were asked to fill out the validated Spanish version of the ICIQ-OAB questionnaire at that same consultation, one time only. The patients were divided into ten-year age groups starting at 18 years of age. The data were analyzed through descriptive statistics.
Results: There were questionnaires from 352 participants at the time of the intermediate analysis. A total of 72% (n = 253) reported urgency as the key symptom of overactive bladder (78 vs 66% in women and men, respectively, p‹0.05). Moderate-severe symptoms were reported in 16% of the patients above the age of 57 years. Severe symptoms were more frequent in women (68%). A total of 31% of the patients described a moderate-severe impact on quality of life. The main concomitant symptom was nocturia (81%) but urge incontinence was the most bothersome symptom for patients (32%).
Conclusion: The prevalence of urgency (the cardinal symptom of overactive bladder) was high in a population in Mexico City.


REFERENCES

  1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology 2003;61(1):37-49. doi:10.1016/S0090-4295(02)02243-4.

  2. Haylen BT, de Ridder D, Freeman RM, et al. An international Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010;29(1):4-20. doi:10.1002/nau.20798.

  3. Coyne KS, Sexton CC, Thompson CL, et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: Results from the epidemiology of LUTS (EpiLUTS) study. BJU Int 2009;104(3):352-360. doi:10.1111/j.1464- 410X.2009.08427.x.

  4. Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50(6):1306-1315. doi:10.1016/j.eururo.2006.09.019.

  5. McVary KT, Peterson A, Donatucci CF, et al. Use of Structural Equation Modeling to Demonstrate the Differential Impact of Storage and Voiding Lower Urinary Tract Symptoms on Symptom Bother and Quality of Life during Treatment for Lower Urinary Tract Symptoms Associated with Benign Prostatic Hyperplasia. J Urol 2016;196(3):824-830. doi:10.1016/j.juro.2016.04.062.

  6. Lee KS, Choo MS, Seo JT, et al. Impact of overactive bladder on quality of life and resource use: results from Korean Burden of Incontinence Study (KOBIS). Health Qual Life Outcomes 2015;13(1):89. doi:10.1186/s12955-015-0274-9.

  7. Irwin DE, Kopp ZS, Agatep B, Milsom I, Abrams P. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int 2011;108(7):1132-1138. doi:10.1111/j.1464-410X.2010.09993.x.

  8. Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K. Understanding the elements of overactive bladder: Questions raised by the EPIC study. BJU Int 2008;101(11):1381-1387. doi:10.1111/j.1464-410X.2008.07573.x.

  9. Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: Results from EpiLUTS. BJU Int 2011;108(9):1459-1471. doi:10.1111/j.1464- 410X.2010.10013.x.

  10. Hashim H, Abrams P. Overactive bladder: an update. Curr Opin Urol 2007;17(4):231-236. doi:10.1097/ MOU.0b013e32819ed7f9.

  11. Abrams P, Avery K, Gardener N, Donovan J. The International Consultation On Incontinence Modular Questionnaire: www.iciq.net. J Urol 2006;175(3):1063-1066. doi:10.1016/ S0022-5347(05)00348-4.

  12. Castro-Díaz DM, Esteban-Fuertes M, Salinas-Casado J, et al. Evaluación de las propiedades psicométricas de la versión en español del cuestionario ICIQ-Male Lower Urinary Tract Symptoms (ICIQ-MLUTS) en España. Actas Urol Esp 2014;38(2):71-77. doi:10.1016/j.acuro.2013.07.005.

  13. Espuña-Pons M, Rebollo-Álvarez P, Puig-Clota M. Validación de la versión española del International Consultation on Incontinence Questionnaire-Short Form. Un cuestionario para evaluar la incontinencia urinaria. Med Clin (Barc) 2004;122(8):288-292. doi:10.1157/13058677.

  14. Castro D, Espuña M, Prieto M, Badia X. Prevalencia de vejiga hiperactiva en españa : estudio poblacional. Arch Esp Urol 2005;58(2):131-138.

  15. Van Den Eeden SK, Shan J, Jacobsen SJ, et al. Evaluating racial/ethnic disparities in lower urinary tract symptoms in men. J Urol 2012;187(1):185-189. doi:10.1016/j. juro.2011.09.043.

  16. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011;77(5):1081-1087. doi:10.1016/j.urology.2010.08.039.

  17. García-Sánchez D, Gutiérrez-González A, Pérez-Ortega R, Gastelum-Félix LA, Reyes-Gutiérrez M. Frecuencia de la vejiga hiperactiva en médicos generales. Rev Mex Urol 2014;74(2):84-87. doi:10.1016/S2007-4085(15)30017-3.

  18. Shy M, Fletcher SG. Objective Evaluation of overactive bladder: which surveys should i use? Curr Bladder Dysfunct Rep 2013;8(1):45-50. doi:10.1007/s11884-012-0167-2.

  19. Agarwal A, Eryuzlu LN, Cartwright R, et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur Urol 2014;65(6):1211-1217. doi:10.1016/j. eururo.2014.01.019.

  20. Vaughan CP, Johnson TM, Ala-Lipasti MA, et al. The prevalence of clinically meaningful overactive bladder: Bother and quality of life results from the population-based FINNO study. Eur Urol 2011;59(4):629-636. doi:10.1016/j. eururo.2011.01.031.

  21. Gonzalez-Sanchez B, Cendejas-Gomez J, Alejandro Rivera- Ramirez J, et al. The correlation between lower urinary tract symptoms (LUTS) and erectile dysfunction (ED): results from a survey in males from Mexico City (MexiLUTS). World J Urol 2016;34(7):979-983. doi:10.1007/s00345- 015-1703-4.




2020     |     www.medigraphic.com